A drug developed by Roche extended the lives of patients with an aggressive form of breast cancer by longer than ever before, the company said, as patents on a key oncology drug approach expiry.
from WSJ.com: What’s News US http://ift.tt/Yv72Ac
from Bobby Caples
from WordPress http://ift.tt/1vjnHDk
from Bobby Caples
No comments:
Post a Comment